声明: 本网站大部分资源来源于用户创建编辑，上传，机构合作，自有兼职答题团队，如有侵犯了你的权益，请发送邮箱到feedback@deepthink.net.cn 本网站将在三个工作日内移除相关内容,刷刷题对内容所造成的任何后果不承担法律上的任何义务或责任
The indication application is based on the data from the SCC244-108 a pivotal Phase II study (GLORY study), a global multi-center, open-label, single-arm clinical trial to evaluate the efficacy and safety of Gumarontinib in locally advanced or metastatic NSCLC patients withMETex14 skipping ...